Anhedonia in Bipolar Depression: Symptoms and Treatment
Anhedonia, the loss of interest or pleasure in activities a person used to enjoy, is one of the core features of a depressive episode in bipolar disorder. It is not simply sadness. A person with anhedonia may feel emotionally flat even when good things happen, lose interest in hobbies, relationships, or food, and struggle to feel motivated even when nothing specific is wrong. Because anhedonia can persist after other symptoms like sleep problems or low energy start to improve, and because some of the usual tools for treating depression carry added risks in bipolar disorder, it often needs its own focused attention rather than being treated as an automatic side effect of "depression getting better."
Treating anhedonia well in bipolar depression generally means combining an accurate diagnosis, coordinated care between a prescriber and a therapist, and a willingness to track pleasure and interest as their own symptom domain, separate from mood, sleep, or appetite.
What Anhedonia Looks Like in Bipolar Depression
For a major depressive episode, either depressed mood or markedly diminished interest or pleasure must be present, along with other required symptoms and diagnostic criteria; both are not required. This applies whether the depressive episode occurs in major depressive disorder or in bipolar disorder. Researchers increasingly think about anhedonia as a problem with the brain's reward processing, meaning the systems involved in anticipating, experiencing, and learning from pleasurable or rewarding experiences, rather than just a mood state. This is an active area of research, and the exact mechanisms are not fully settled, but it helps explain why anhedonia does not always track neatly with how "depressed" someone reports feeling.
Bipolar depression also differs from depression in major depressive disorder in a clinically important way: many standard antidepressant strategies carry a risk of triggering hypomania, mania, or mixed states in people with bipolar disorder. This is why an accurate diagnosis matters before anhedonia, or any depressive symptom, is treated. A bipolar disorder evaluation that confirms the diagnosis and reviews episode history is the starting point for safe treatment planning, not an optional extra step.
Watch the video: Understanding Bipolar Depression (Stanford Health Care)
Building a Team-Based Approach to Anhedonia in Bipolar Depression
Because bipolar depression treatment has to balance symptom relief against the risk of mood switching, care usually works best when a prescriber and a therapist are coordinating rather than working in isolation.
The prescriber's role typically includes confirming the bipolar diagnosis, reviewing current and past episodes, and managing medication in a way that addresses depressive symptoms, including anhedonia, without destabilizing mood. This often means starting with or maintaining a mood stabilizer or an agent specifically studied for bipolar depression before considering an antidepressant, and if an antidepressant is used, doing so cautiously and usually alongside a mood stabilizer, with monitoring for signs of hypomania or agitation.
The therapist's role often includes structured psychotherapy that targets behavior and routine, not just thoughts about mood. For bipolar disorder specifically, interpersonal and social rhythm therapy (IPSRT) is a well-studied approach that focuses on stabilizing sleep and daily routines, since disrupted circadian rhythms are closely tied to mood episodes in bipolar disorder. Cognitive behavioral therapy and behavioral activation, discussed in more detail below, are also commonly used.
Family and caregiver involvement matters because anhedonia is easy to misread as laziness, lack of motivation, or not trying hard enough. It is a symptom, not a character flaw, and framing it that way to family members can reduce conflict and improve follow-through with treatment.
Tracking anhedonia specifically is a practical step clinicians can take during follow-up visits. Asking directly about interest and pleasure in specific activities, rather than only asking "how is your mood," helps distinguish whether anhedonia is improving, unchanged, or lagging behind other symptoms.
Bipolar depression treatment when pleasure is missing
No single treatment reliably resolves anhedonia for every person with bipolar depression. The options below are generally used in combination, under clinical supervision, rather than as standalone fixes.
Psychotherapy approaches
- Behavioral activation works by scheduling activities that are enjoyable or that provide a sense of accomplishment, even before motivation naturally returns. The idea is that engaging in activity, even reluctantly, can help rebuild the connection between action and reward over time.
- Cognitive behavioral therapy (CBT) helps identify and adjust thought patterns that reduce anticipation of pleasure, such as assuming an activity will not be enjoyable before trying it, and uses activity monitoring to track mood and engagement.
- Interpersonal and social rhythm therapy (IPSRT) stabilizes sleep-wake timing and daily routines, which is particularly relevant in bipolar disorder because circadian disruption is linked to both depressive and manic episodes.
Medication approaches
Current bipolar disorder treatment guidelines generally favor mood stabilizers or specific agents studied and approved for bipolar depression, such as certain atypical antipsychotics, over standard antidepressant monotherapy, because of the mania-switch risk mentioned earlier. If an antidepressant is added, it is typically combined with a mood stabilizer and monitored closely. Whether a specific medication will meaningfully improve anhedonia, as opposed to other depressive symptoms, is not something that can be predicted from a published average response rate. Response varies by individual, and this decision should be made with a prescriber who has reviewed the full diagnostic and treatment history.
Neuromodulation and newer treatments
Transcranial magnetic stimulation (TMS), including the NeuroStar system offered at Sophroneo Behavioral Health & TMS, is FDA-cleared for major depressive disorder. Its use specifically in bipolar depression is less established in the research literature, and a clinician will typically want to confirm mood stability on a mood stabilizer and weigh individual history before considering it, since stimulation therapies can carry switch-risk considerations similar to antidepressants in some patients. This is an individualized clinical decision, not an automatic option for everyone with bipolar depression.
Current Spravato labeling permits treatment-resistant depression in adults either alone or with an oral antidepressant. The separate indication for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior requires an oral antidepressant. Administration and monitoring take place under clinical supervision. It does not carry an FDA-approved indication for bipolar depression. Ketamine-based treatments for bipolar depression are an area of ongoing research, but using esketamine or ketamine outside their labeled indications in bipolar disorder is an off-label decision that requires careful specialist evaluation, not a routine substitute for standard bipolar depression treatment. Information on the clinic's Spravato program describes the approved use; any application to bipolar depression should be discussed directly with a prescriber.
Lifestyle and adjunct strategies
Regular physical activity and consistent sleep timing are commonly recommended alongside formal treatment, since both relate to mood and reward regulation. Bright light therapy is sometimes used for depression, but in bipolar disorder it requires caution and monitoring, because it has been associated with triggering hypomanic or manic symptoms in some individuals. These strategies work best as additions to, not replacements for, the core treatment plan.
Putting Anhedonia Treatment Into a Bipolar Care Plan
The practical takeaway is that anhedonia in bipolar depression responds best to a plan that is individualized, coordinated between prescriber and therapist, and reviewed regularly rather than assumed to resolve automatically once other depressive symptoms improve. A reasonable starting point is a thorough psychiatric evaluation that confirms the bipolar diagnosis and reviews episode history, followed by a treatment plan that addresses mood stability first and anhedonia specifically within that frame, using psychotherapy, medication adjustments, or additional options as appropriate for the individual.
If loss of interest or pleasure has lasted two weeks or more and is affecting daily functioning, relationships, or work, that is generally a reasonable point to seek a clinical evaluation rather than waiting to see if it resolves on its own.
If anhedonia is accompanied by hopelessness, thoughts of self-harm, or thoughts of suicide, this is a safety concern that should not wait for a routine appointment. The 988 Suicide & Crisis Lifeline can be reached by calling or texting 988, or online at [988lifeline.org](https://988lifeline.org/). If there is immediate danger, call 911 or go to the nearest emergency department.
For routine evaluation or follow-up care, Sophroneo Behavioral Health & TMS offers psychiatric evaluation and ongoing management for bipolar disorder at its Powder Springs and Marietta, Georgia locations. Readers can review bipolar disorder care or contact the practice to ask about scheduling an evaluation and to confirm which services and appointment types are currently available.
Sources
For diagnostic and treatment context, see NIMH’s Bipolar Disorder guide. For the approved indications, limitations, and safety requirements of esketamine, see the current Spravato prescribing information. These sources support a discussion with a qualified clinician; they do not determine an individual treatment plan.
Frequently Asked Questions
Q: Is anhedonia the same thing as feeling sad?
A: No. Sadness is a mood state, while anhedonia is a reduced ability to feel interest or pleasure, even in things a person previously enjoyed. Someone can have low anhedonia with significant sadness, or notable anhedonia with relatively flat rather than sad mood. Both are recognized symptoms of a depressive episode under DSM-5-TR criteria, and they do not always improve at the same rate with treatment.
Q: Can antidepressants treat anhedonia in bipolar depression?
A: Antidepressants can be part of treatment, but in bipolar disorder they are generally used cautiously and typically combined with a mood stabilizer, because antidepressant use alone carries a risk of triggering hypomania, mania, or mixed states in some people with bipolar disorder. Many current treatment approaches for bipolar depression start with mood stabilizers or medications specifically studied for bipolar depression before adding an antidepressant. This decision should be individualized with a prescriber who has reviewed the full history.
Q: Does TMS specifically treat anhedonia in bipolar depression?
A: TMS, including the NeuroStar system, is FDA-cleared for major depressive disorder, not specifically for bipolar depression. Evidence on its use in bipolar depression is more limited, and clinicians typically want mood stability confirmed before considering it. Whether TMS is appropriate for a particular person with bipolar depression and anhedonia is an individualized decision made with a treating clinician.
Q: Is Spravato approved for bipolar depression?
A: No. Spravato has no FDA-approved indication for bipolar depression. Its adult treatment-resistant depression indication allows use alone or with an oral antidepressant; the separate indication involving acute suicidal ideation or behavior requires an oral antidepressant. Any proposed use for bipolar depression needs specialist assessment and an explicit discussion of off-label treatment.
Q: What should I do if loss of pleasure is accompanied by hopelessness or thoughts of suicide?
A: This should be treated as urgent, not something to wait out until a routine appointment. In the United States, you can call or text 988 to reach the Suicide & Crisis Lifeline, or visit 988lifeline.org. If there is immediate danger, call 911 or go to the nearest emergency department.
Comments